1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2026Association between relative handgrip strength and metabolic syndrome in Korean postmenopausal women by time since menopauseMENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY
2025Consistent Ovulation Window Prediction based on Physiological Temporal Variability Patterns from Wearable Devices2025 47TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC)
2022Fetus Prenatally Diagnosed with Lobar Holoprosencephaly Postnatally Diagnosed with Simple Hydrocephalus with Good Prognosis: A Case ReportPerinatology
2026Efficacy of Chemotherapy Following Prior PARP-Inhibitor Treatment in Patients with Ovarian CancerCANCER RESEARCH AND TREATMENT
2026Immune regulation and lymphangiogenesis by lymphatic endothelial cells in the decidua in severe preeclampsia SCIENTIFIC REPORTS
2026Pembrolizumab plus lenvatinib in recurrent gynaecological clear cell carcinoma (LARA): a multicentre, single-arm phase 2 trialLANCET ONCOLOGY
2026Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/ SHAPE trial GYNECOLOGIC ONCOLOGY
2026Leveraging tumor multigene panel testing to identify germline variants in gynecologic cancers: A retrospective evaluation of an algorithm-based approachGYNECOLOGIC ONCOLOGY
2026Integrative Multi-Omics Analysis Reveals Molecular Signatures of Recurrence in Paired Primary and Recurrent High-Grade Serous Ovarian Cancer INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2025Minimally invasive compared to open surgery in patients with low-risk cervical cancer following simple hysterectomy: An exploratory analysis from the Gynegologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trialInternational Journal of Gynecological Cancer
2025TIP25-243: Randomized Study Evaluating Optimal Dose, Efficacy and Safety of E7386 + Lenvatinib Versus Treatment of Physicians' Choice in Advance/Recurrent Endometrial Carcinoma Previously Treated With Anti-PD-(L)1 ImmunotherapyJNCCN Journal of the National Comprehensive Cancer Network
2026Utility of CA125 KELIM in predicting benefit from hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer: pooled analysis of KGOG3042 and KOV-HIPEC-01INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2026Formation of an endometrial epithelial monolayer in a microfluidic device with human tissue-derived endometrial organoidsLAB ON A CHIP
2025Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancerGYNECOLOGIC ONCOLOGY
2025An Open-Label, Multicentre, Phase 2 Study Of Trastuzumab Deruxtecan In Patients With HER2-Expressing Solid Tumours: DESTINY-PanTumor02 Part 2INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2025A Phase III Randomized Controlled Trial In Primary Stage Three And Four Ovarian Cancer After Interval Cytoreductive Surgery (FOCUS)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2025Single-Cell RNA Sequencing Analysis Highlights M2-Like Tumor-Associated Macrophages' Role In Poor Response To Radiotherapy In Cervical CancerINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2025Phosphatidylserine Decarboxylase Overexpression Induced Reprogramming Of Fatty Acid Metabolism Confers And Platinum Based Chemoresistance In P53 Dependent Manner In Epithelial Ovarian CancerINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2025Modifying surgical extents in patients with preoperatively presumed early-stage endometrial cancer based on ProMisE classification: a retrospective, single-center study JOURNAL OF GYNECOLOGIC ONCOLOGY
2025The 2nd Annual Meeting of the East Asian Gynecologic Oncology Trial Group (EAGOT) JOURNAL OF GYNECOLOGIC ONCOLOGY

Recent Submissions

Browse

Links